NATHBIOGEN

Nath Bio-Genes (India) Share Price Nath Bio-Genes (India)

₹174.05
-1.9 (-1.08%)
29 March, 2024 01:15 BSE: 537291 NSE: NATHBIOGENISIN: INE448G01010

Start SIP in Nath Bio-Genes (India)

Start SIP

Nath Bio-Genes (India) Performance

Day Range

  • Low 173
  • High 183
₹ 174

52 Week Range

  • Low 139
  • High 245
₹ 174
  • Open Price177
  • Previous Close176
  • Volume86935

Nath Bio-Genes (India) Share Price

  • Over 1 Month -14.99%
  • Over 3 Month -15.84%
  • Over 6 Month -15.37%
  • Over 1 Year 25.8%

Nath Bio-Genes (India) Key Statistics

P/E Ratio 8.1
PEG Ratio 0.1
Market Cap Cr 331
Price to Book Ratio 0.6
EPS 18.5
Dividend 1.1
Relative Strength Index 30.16
Money Flow Index 25.64
MACD Signal -7.87
Average True Range 8.34
Nath Bio-Genes (India) Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 322323545
Operating Expenses Qtr Cr 261719841
Operating Profit Qtr Cr 66374
Depreciation Qtr Cr 1111
Interest Qtr Cr 3232
Tax Qtr Cr 1000
Net Profit Qtr Cr 42332
IndicatorMar 2023
Total Revenue Annual Cr 302
Operating Expenses Annual Cr 252
Operating Profit Annual in Cr 49
Depreciation Cr 3
Interest Annual Cr 10
Tax Annual Cr 1
Net Profit Annual Cr 35
IndicatorMar 2023
Cash from Operating Activity Annual Cr 38
Cash from Investing Activity Annual Cr -3
Cash from Financing Annual Activity Cr -2
Net Cash Flow Annual Cr 34
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 573
Fixed Assets Annual Cr 244
Total Non Current Assets Annual Cr 272
Total Current Assets Annual Cr 521
Total Assets Annual Cr 793
IndicatorMar 2023
Book Value Per Share Annual Rs 302
ROE Annual % 6
ROCE Annual % 8
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 16
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 3223235
Operating Expenses Qtr Cr 2617198
Operating Profit Qtr Cr 6637
Depreciation Qtr Cr 111
Interest Qtr Cr 323
Tax Qtr Cr 100
Net Profit Qtr Cr 4233
IndicatorMar 2023
Total Revenue Annual Cr 302
Operating Expenses Annual Cr 253
Operating Profit Annual in Cr 49
Depreciation Cr 3
Interest Annual Cr 10
Tax Annual Cr 1
Net Profit Annual Cr 35
IndicatorMar 2023
Cash from Operating Activity Annual Cr 38
Cash from Investing Activity Annual Cr -3
Cash from Financing Annual Activity Cr -2
Net Cash Flow Annual Cr 34
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 573
Fixed Assets Annual Cr 244
Total Non Current Assets Annual Cr 272
Total Current Assets Annual Cr 521
Total Assets Annual Cr 793
IndicatorMar 2023
Book Value Per Share Annual Rs 302
ROE Annual % 6
ROCE Annual % 8
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 16

Nath Bio-Genes (India) Technicals

EMA & SMA

Current Price
₹174.05
-1.9 (-1.08%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹187.30
  • 50 Day
  • ₹197.76
  • 100 Day
  • ₹201.56
  • 200 Day
  • ₹199.58
  • 20 Day
  • ₹188.09
  • 50 Day
  • ₹204.70
  • 100 Day
  • ₹204.08
  • 200 Day
  • ₹205.64

Nath Bio-Genes (India) Resistance and Support

PIVOT
₹176.69
Resistance
First Resistance 180.27
Second Resistance 186.48
Third Resistance 190.07
RSI 30.16
MFI 25.64
MACD Single Line -7.87
MACD -8.41
Support
First Resistance 170.47
Second Resistance 166.88
Third Resistance 160.67

Nath Bio-Genes (India) Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 111,789 7,293,114 65.24
Week 81,462 5,884,833 72.24
1 Month 60,121 4,055,759 67.46
6 Month 94,182 5,728,128 60.82

Nath Bio-Genes (India) Result Highlights

Nath Bio-Genes (India) Synopsis

NSE-Agricultural Operations

Nath Bio-Genes is involved in the business activities of Growing of non-perennial crops. Company’s Total Operating Revenue is Rs. 301.29 Cr. and Equity Capital is Rs. 19.00 Cr. for the Year ended 31/03/2023. Nath Bio-Genes (India) Ltd. is a Public Limited Listed company incorporated on 14/07/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L01110MH1993PLC072842 and registration number is 072842.
Market Cap 331
Sales 335
Shares in Float 1.03
No of funds 13
Yield 1.14
Book Value 0.57
U/D Vol ratio 1.6
LTDebt / Equity
Alpha -0.06
Beta 1.31

Nath Bio-Genes (India)

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 45.6%45.6%45.6%45.6%
Mutual Funds 4.37%4.37%4.62%4.62%
Foreign Portfolio Investors 0.32%0.22%0.07%0.13%
Financial Institutions/ Banks
Individual Investors 30.96%30.5%30.37%30.17%
Others 18.75%19.31%19.34%19.48%

Nath Bio-Genes (India) Management

Name Designation
Mr. Satish Kagliwal Managing Director
Mr. Madhukar Deshpande Director
Ms. Ashu Jain Director
Mrs. Jeevanlata Kagliwal Director
Mr. Vadla Nagabhushanam Director
Mrs. Sweta Kagliwal Director
Mr. Hitesh Purohit Director

Nath Bio-Genes (India) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Nath Bio-Genes (India) Corporate Action

Date Purpose Remarks
2024-01-18 Quarterly Results
2023-10-16 Quarterly Results
2023-08-10 Quarterly Results
2023-04-22 Audited Results & Final Dividend
2023-02-14 Quarterly Results

Nath Bio-Genes (India) MF Shareholding

Nath Bio-Genes (India) FAQs

What is Share Price of Nath Bio-Genes (India) ?

Nath Bio-Genes (India) share price is ₹174 As on 29 March, 2024 | 01:01

What is the Market Cap of Nath Bio-Genes (India) ?

The Market Cap of Nath Bio-Genes (India) is ₹330.8 Cr As on 29 March, 2024 | 01:01

What is the P/E ratio of Nath Bio-Genes (India) ?

The P/E ratio of Nath Bio-Genes (India) is 8.1 As on 29 March, 2024 | 01:01

What is the PB ratio of Nath Bio-Genes (India) ?

The PB ratio of Nath Bio-Genes (India) is 0.6 As on 29 March, 2024 | 01:01

Q2FY23